logo
‘You can literally pregame recess with these': Experts warn of caffeine pouches targeting teens

‘You can literally pregame recess with these': Experts warn of caffeine pouches targeting teens

Independent2 hours ago
Last summer, a TikTok user shared a video responding to a commenter asking if 13-year-olds can use caffeine pouches. The pouches, which are placed between your cheeks and gums to absorb the stimulant directly, have become increasingly popular amongst teens.
'Yes, guys, you can literally pregame recess with these,' the video creator says, holding up a tin of LyvWel 'Cherry Blast' caffeine pouches.
There are a lot of similar videos all over TikTok.
'Can a 13-year-old use or buy upper-deckies from the TikTok shop? Yeah, of course you can,' a different user said, referencing the popular online nickname for pouch products. 'These are literally just caffeine pouches.'
There is no national age restriction on caffeine in the U.S., so anyone can purchase products that contain the stimulant. Caffeine use in kids can even result in a hospital trip, which is rare but on the rise. The number of children ages 11 to 14 who had to visit the emergency room due to a caffeine overdose doubled between 2017 and 2023, according to a November 2024 study.
And experts are getting increasingly concerned about the impact of caffeine on children, and the marketing tactics that could expose kids to these products.
Dr. Michael Garcia, an internal medicine doctor with a focus on nutrition at UCLA Health, told The Independent that 'less is more' when it comes to caffeine for adolescents. Long-term use among teens can increase blood pressure, worsen anxiety and impact sleep, he explained.
'We know caffeine is one of those things our body can develop tolerance to,' Garcia said. 'So little by little, maybe use increases as that tolerance develops. And it's like any other stimulant or substance that gives us some sort of immediate effect, we then depend on it ... long-term.'
The American Academy of Pediatrics suggests 100mg as the upper limit for kids 12-18, which is about the equivalent of a cup of drip coffee, about two cans of Diet Coke, or one energy drink.
There are several other companies that sell caffeine pouches, including Deckiez, Rebel Pouches, and Wip, a caffeine pouch start-up founded by Richard Mumby, a strategic investor and marketing executive who worked with the e-cigarette company Juul.
Different brands have different amounts of caffeine: many of LyvWel's pouches contain 56mg per pouch, which is roughly equivalent to a can of soda. Deckiez sells pouches with 40mg and 50mg of caffeine. Wip sells products with 100mg and 200mg of caffeine per pouch, with 15 pouches per package.
Wip's Instagram features influencers over 18 promoting the products while doing athletic activities, including surfing, skateboarding and weightlifting. Rebel Pouches' Instagram shows men playing golf, softball and running, amongst other sports. Deckiez, founded by a teenager and his father, shows the now-college student founder talking with other young men, and shows people snowboarding and playing softball. LyvWel's focuses on discount prices and flavor variety.
Dr. Robert Jackler, founder of the Stanford Research Into the Impact of Tobacco Advertising group, tells The Independent he's concerned social media marketing tactics could make teens eager to try the products, pointing out Wip's use of sports teens are particularly attracted to.
'These videos of the skateboarder doing his tricks…I mean, there may be 50-year-olds and 30-year-olds who are interested in that, but it clearly has a differential interest amongst young people,' he said.
Dr. Bonnie Halpern-Felsher, a developmental psychologist at Stanford Medicine, also argued that using influencers and sporty imagery indicates it's 'clearly being marketed to young people.'
'You could talk about users on the way to the office, on the way to a business meeting…that would be much more obvious that you're targeting adults,' she said. 'There's nothing that I can see of the sort here. It is all fun and games.'
However, caffeine pouch companies claim that they only aim their products to over-18s and, there's age-related warnings on the tin.
Wip rejects any suggestion that they have advertised to underage children, with the company noting that its packaging is designed to appeal to adults and that hiring influencers is normal marketing practice. The product also includes age and usage recommendations, including a warning that says Wip is intended for people 18 and older.
'Wip has adopted an exceptionally proactive and responsible marketing approach, grounded in and exceeding official health authority guidelines,' the company said in a statement to The Independent.
Deckiez founders Dean and Mike Herkenrath noted that their product was created 'as a healthier alternative to the huge spike in nicotine pouch use' and pointed out that caffeine has some health benefits for adults. For instance, studies have shown that adult coffee drinkers are less likely to develop heart failure, according to Johns Hopkins Medicine.
'Many of our customers have quit or heavily reduced their nicotine pouch consumption and we're very proud of that,' the Herkenraths said in a statement. 'Our social media content is indented for success minded young adults to ageless at heart seeking to energize their goals!'
LyvWel said in a statement to The Independent that the TikTok creators encouraging 13-year-olds to try their caffeine pouches are not affiliated with the company, and appear to be using 'TikTok's Affiliate Program, which allows any user regardless of age to tag and promote TikTok shop products without brand involvement or approval.'
The company says it has tried to report 'several inappropriate videos,' but some haven't been taken down. The Independent has contacted TikTok for comment.
As interest in caffeine pouches grows, Dr. Grace Kong, a psychiatry professor at Yale Medicine who specializes in child and adolescent psychology, told The Independent that adolescents don't have all the tools they need to make informed decisions about caffeinated products, especially those they find on social media.
'There is an issue if we're targeting that kind of advertising or marketing to teens for those substances, because teens are still minors,' she told The Independent. 'There still needs to be protection in some way about the decision-making.'
She noted that she thinks caffeine pouches are too similar in design to nicotine pouches, which could encourage young people to try them. 'It could be a gateway, or it could really normalize pouch use,' Kong said.
There's also concern about how the caffeine is being delivered through these pouches, Dr. Taylor Argo, an adolescent medicine fellow at the University of Michigan, told The Independent.
'There are lots of blood vessels right there, and so that caffeine is being absorbed directly into the bloodstream…we hypothesize that when you put medicines directly into your mouth that way, or other substances, it's absorbed a little faster,' she said.
The 'biggest risk factor' for teens when using high levels of caffeine is irregular heart rates, also known as cardiac arrhythmias, Argo said.
'I actually have not heard of any of my patients using these, and I care for teens every day…I do worry about the amount of caffeine that is in it and how it's being delivered,' she added.
Garcia encourages parents to talk about caffeine products with their teens and learn why they might want to use them.
'I think as adults, we are always inclined to provide a solution, but I think there's a lot of value in listening,' he said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Miplyffa (arimoclomol)
Miplyffa (arimoclomol)

Medical News Today

time43 minutes ago

  • Medical News Today

Miplyffa (arimoclomol)

Miplyffa is a brand-name oral capsule. It's prescribed for symptoms that affect the brain, spinal cord, and nerves in people with a rare genetic condition. Miplyffa contains the active ingredient arimoclomol. Specifically, the Food and Drug Administration (FDA) has approved Miplyffa to treat symptoms that affect the brain, spinal cord, and nerves in people with Niemann-Pick disease type C. It's prescribed for adults and children ages 2 years and detailsYou'll find key information about Miplyffa here:Drug class: heat shock protein stimulatorDrug form: oral capsuleGeneric available? noPrescription required? yesControlled substance? noMiplyffa genericMiplyffa is available only as a brand-name medication. It's not currently available in generic form.A generic drug is an exact copy of the active ingredient in a brand-name medication. Generics usually cost less than brand-name dosageThe Miplyffa dosage your doctor prescribes will depend on several factors. These include:your body weight in kilograms (kg)other medical conditions you may haveFor reference, 1 kg is about 2.2 pounds (lb).The following information describes dosages that are commonly used or recommended. However, be sure to take the dosage your doctor prescribes for you. Your doctor will determine the best dosage to fit your form and strengthsMiplyffa comes as an oral capsule. It's available in four strengths:47 milligrams (mg)62 mg93 mg124 mgDosage for Niemann-Pick disease type CMiplyffa is prescribed to treat symptoms that affect the brain, spinal cord, and nerves caused by Niemann-Pick disease type C. It's prescribed for adults and children ages 2 years and typical dosage of Miplyffa depends on body weight as outlined below:8 kg to 15 kg (about 17 lb to 33 lb): 47 mg three times dailymore than 15 kg to 30 kg (about 33 lb to 66 lb): 62 mg three times dailymore than 30 kg to 55 kg (about 66 lb to 121 lb): 93 mg three times dailymore than 55 kg (about 121 lb): 124 mg three times dailyYour doctor may prescribe a different dosage depending on certain factors, such as your kidney function. If you have questions about the Miplyffa dosage that's right for you, talk with your taking MiplyffaYou'll find information about key dosage issues here:When to take: You should take Miplyffa three times daily, around the same time each day. This helps keep a steady level of the drug in your body so the drug can work you miss a dose: If you miss a dose of Miplyffa, skip it. Then take your next dose at the regular Miplyffa with food: You can take Miplyffa with or without splitting, or chewing Miplyffa: If possible, Miplyffa capsules should be swallowed whole. But if you have trouble swallowing capsules, you can open them. Sprinkle the contents onto 15 milliliters (mL) of apple juice, water, or a soft food such as yogurt or applesauce. Take the mixture right away. If you use a feeding tube, you can mix the capsule contents with 20 mL of water and give the mixture through the tube. Be sure to flush the tube with 5 mL of water afterward. Length of use: Miplyffa is meant to be a long-term treatment. If you and your doctor determine that Miplyffa is safe and effective for you, you'll likely take it long of time to work: Miplyffa starts to work after your first dose. Your doctor will monitor your condition to determine how well the drug is side effectsMiplyffa can cause mild or serious side effects. The following lists contain some of the key side effects that may occur while taking Miplyffa. These lists do not include all possible side more information about the possible side effects of Miplyffa, talk with your doctor or pharmacist. They can give you tips on how to manage any side effects that may be concerning or After the Food and Drug Administration (FDA) approves a drug, it tracks and reviews side effects of the medication. Sharing your experience helps make medications safer for everyone by giving doctors and researchers more information about how the drug works in real life. If you develop a side effect while taking Miplyffa and want to tell the FDA about it, visit MedWatch or call side effectsHere is a partial list of mild side effects of Miplyffa. To learn about other mild side effects, talk with your doctor or pharmacist, or view Miplyffa's prescribing side effects of Miplyffa can include:diarrheaheadachehivesloss of appetiteseizuretremorupper or lower respiratory tract infectionweight lossMost of these side effects may go away within a few days to a couple of weeks. However, if they become more severe or don't go away, talk with your doctor or side effectsSerious side effects from Miplyffa aren't common, but they can occur. Call your doctor right away if you have serious side effects. Call 911 or your local emergency phone number if your symptoms feel life threatening or you think you're having a medical side effects can include high creatinine levels, which may affect how kidney function is REACTIONFor some people, Miplyffa can cause an allergic general, symptoms of an allergic reaction can be mild or to manageFor mild allergic reaction symptoms, such as a mild rash, call your doctor right away. They may recommend treatments to help manage your symptoms. They'll also let you know whether you should keep taking the severe allergic reaction symptoms, such as swelling or trouble breathing, call 911 or your local emergency number right away. These symptoms require immediate medical care because they can become life threatening. If you've had a serious allergic reaction to Miplyffa, your doctor may recommend a different medication usesThe following information describes Miplyffa's approved use by the Food and Drug Administration (FDA).Miplyffa for Niemann-Pick disease type CMiplyffa is approved to treat symptoms that affect the brain, spinal cord, and nerves in people with Niemann-Pick disease type C (NPC). It's prescribed for adults and children ages 2 years and is a rare genetic condition that affects how the body stores and removes cholesterol and other fats. Over time, these fats build up in the brain and other parts of the body. This can lead to worsening symptoms that may affect the brain, spinal cord, and nerves. Symptoms of NPC may include seizures and difficulty walking, balancing, speaking, or this purpose, Miplyffa is typically prescribed with miglustat (Opfolda, Yargesca, others). Together, these medications may help slow the worsening of NPC learn more about Miplyffa for NPC, talk with your and childrenMiplyffa is approved to treat NPC in children ages 2 years and learn more about Miplyffa for children with NPC, talk with your child's interactionsMiplyffa can interact with several other medications. However, the drug isn't known to interact with any supplements or taking Miplyffa, talk with your doctor and pharmacist. Tell them about all prescription, over-the-counter, and other drugs you take. Also tell them about any vitamins, herbs, and supplements you use. Sharing this information can help you avoid potential with medicationsHere is a list of medications that can interact with Miplyffa. This list does not contain all drugs that may interact with Miplyffa. If you have questions about drug interactions that may affect you, ask your doctor or that can interact with Miplyffa• cisplatin (Kemoplat)• cimetidine (Tagamet HB)• ipratropium (Atrovent HFA)• lamivudine (Epivir)• metformin (Glumetza)Alcohol interactionAlcohol is not known to interact with Miplyffa. If you have questions about whether it's safe to drink alcohol while taking Miplyffa, talk with your doctor or cost and savingsAs with all medications, the cost of Miplyffa can vary. The actual price you'll pay depends on your insurance plan, your location, and the pharmacy you and insurance assistance: If you need financial support to pay for Miplyffa or help understanding your insurance coverage, help is available.A program called AmplifyAssist is available for Miplyffa. For more information and to find out if you're eligible for support, call 888-668-4198 or visit the program version: Miplyffa is not available in a generic form. A generic drug is an exact copy of the active ingredient in a brand-name medication. Generics tend to cost less than brand-name drugs.»Learn more about saving money on drugsOther drugs are available that can treat Niemann-Pick disease type C. Examples include levacetylleucine (Aqneursa) and miglustat (Opfolda, Yargesca, others).Some drugs may be a better fit for you than others. If you're interested in finding an alternative to Miplyffa, talk with your doctor. They can tell you about other medications that may work well for to consider when taking Miplyffa If you can become pregnant, consider the following information about pregnancy, fertility, birth control, and and pregnancy It may not be safe to take Miplyffa during pregnancy. This is based on the results of animal studies, which don't always predict what will happen in humans. If you're planning a pregnancy or can become pregnant, talk with your doctor before taking this medication. Your doctor may suggest birth control options to use during treatment with and fertilityIn animal studies, Miplyffa decreased female and male fertility (the ability to conceive). However, animal studies don't always predict what will happen in starting Miplyffa treatment, talk with your doctor about the drug's possible effects on fertility. They can recommend whether Miplyffa is the right treatment and birth controlMiplyffa may not be safe to take during pregnancy. If you're sexually active and you or your partner can become pregnant, talk with your doctor about your birth control options while you're taking The use of binary terms such as 'male' and 'female' or 'men' and 'women' in this article reflects the language of the sources we've used. Unless otherwise noted, it's unclear whether the research we reference included participants with expansive gender females using MiplyffaDoctors may advise females who can become pregnant to use birth control during Miplyffa treatment. If you're a female taking Miplyffa, talk with your doctor about your birth control males using MiplyffaIf you're a male with a sexual partner who can become pregnant, talk with your doctor about your birth control needs during Miplyffa treatment. Miplyffa and breastfeedingIt's not known whether Miplyffa should be taken while breastfeeding. If you're currently breastfeeding or planning to do so, talk with your doctor before taking this Miplyffa worksMiplyffa's mechanism of action (how it works) is not fully understood. Miplyffa is used to treat Niemann-Pick disease type C, which is a rare genetic condition that can cause fats to build up in the body. This buildup may lead to symptoms that affect the brain, spinal cord, and nerves. Miplyffa is thought to help slow the worsening of these you have other questions bout how Miplyffa works, talk with your doctor or precautionsCertain factors or conditions could prevent your doctor from prescribing Miplyffa due to the risk of harm. These are known as contraindications. However, Miplyffa does not have any known taking Miplyffa, discuss your health history with your doctor. Miplyffa may not be suitable for you if you have specific medical conditions or other health factors. Be sure to talk with your doctor if any of the following apply to you:kidney problemsprevious allergic reaction to this or a similar drugpregnancybreastfeedingNote: For more information about the potential negative effects of Miplyffa, see the 'Miplyffa side effects' Medical News Today has made every effort to make certain that all information is factually correct, comprehensive, and up to date. However, this article should not be used as a substitute for the knowledge and expertise of a licensed healthcare professional. You should always consult your doctor or another healthcare professional before taking any medication. The drug information contained herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses.

‘Grave, growing, and underrecognized danger:' New report sheds light on plastic pollution
‘Grave, growing, and underrecognized danger:' New report sheds light on plastic pollution

The Independent

timean hour ago

  • The Independent

‘Grave, growing, and underrecognized danger:' New report sheds light on plastic pollution

The 'underrecognized' and 'grave and growing danger' of pervasive global plastic pollution is a threat to human health throughout the course of our lives, a group of international researchers warned in a report released Monday. With production on track to nearly triple by 2060, plastic pollution is responsible for disease and death and is estimated to cost the U.S. some $1.5 trillion a year in health-related economic losses, they explained, with 8,000 metric tons of plastic waste invading our lands, our water sources, and even our own hearts and brains. In the environment, such waste can provide a habitat for mosquitoes to lay eggs in, spreading deadly infections such as malaria and dengue fever. In our oceans, it can carry bacteria that sickens marine life, choking and killing animals looking for food. Furthermore, airborne emissions from the fossil fuel industry's plastic production are drivers of climate change and expose people to hazardous chemicals. Some three-quarters of plastic chemicals have never been tested for safety, the authors said, even as an estimated 57 percent of plastic waste is burned in the open, leaving low-income and at-risk populations disproportionately in harm's way. 'There is no understating the magnitude of both the climate crisis and the plastic crisis,' Dr. Philip Landrigan, a pediatrician and epidemiologist at Boston College, said in a statement. 'They are both causing disease, death and disability today in tens of thousands of people, and these harms will become more severe in the years ahead as the planet continues to warm and plastic production continues to increase.' Landrigan and the report's other authors called for greater public awareness of the issue – as well as policy to prevent continued worsening of the plastic pollution crisis. Their findings were released in the British medical journal The Lancet ahead of United Nations talks in Switzerland this week, which aim to finalize the world's first plastic pollution treaty following previous failed attempts. ' Plastics are made from fossil fuels, contaminate food and water, are tied to many human illnesses, and impose steep costs for medical care and environmental damage,' Landrigan, the report's lead author, said. To track these and reduce exposures, the researchers announced they had launched an independent and global monitoring system. They said that worsening is not inevitable with action. 'We know a great deal about the range and severity of the health and environmental impacts of plastic pollution across the full life cycle of plastic,' said Landrigan. 'These impacts fall most heavily on vulnerable populations, especially infants and children. They result in huge economic costs to society. It is incumbent on us to act in response.'

New Jersey says 3 chemical makers agree to 'forever chemical' settlement worth up to $2 billion
New Jersey says 3 chemical makers agree to 'forever chemical' settlement worth up to $2 billion

The Independent

timean hour ago

  • The Independent

New Jersey says 3 chemical makers agree to 'forever chemical' settlement worth up to $2 billion

DuPont and two other companies will pay New Jersey up to $2 billion to settle environmental claims stemming from PFAS, commonly referred to as 'forever chemicals," the companies announced Monday. State Environmental Commissioner Shawn LaTourette said the deal with DuPont, Chemours and Corteva is the largest such settlement in the state's history. It calls for the companies to pay $875 million over 25 years and create a remediation fund of up $1.2 billion. The companies will split the costs under the deal, which must still be approved by the courts. PFAS, or perfluoroalkyl and polyfluoroalkyl substances, are a group of chemicals that have been around for decades and have now spread into the nation's air, water and soil. They are commonly referred to as 'forever chemicals.' DuPont said the settlement will resolve 'all pending environmental and other claims' for 'legacy" contamination claims at four sites where the companies operated in the state. It comes just months after the state said chemical manufacturer 3M has agreed to pay up $450 million to resolve lawsuits over natural resource contamination stemming from PFAS. "Polluters who place profit above public well-being by releasing poisonous PFAS and other contamination in our State can expect to be held responsible to clean up their mess and fully compensate the State and its citizens for the precious natural resources they've damaged or destroyed," LaTourette said. PFAS were manufactured by companies such as 3M, Chemours and others because they were incredibly useful. They helped eggs slide across non-stick frying pans, ensured that firefighting foam suffocates flames and helped clothes withstand rain and keep people dry. The chemicals resist breaking down, though, meaning they linger in the environment. Environmental activists say PFAS makers knew about the health harms of PFAS long before they were made public. The same attributes that make the chemicals so valuable – resistance to breakdown – make them hazardous to people. PFAS accumulate in the body, which is why the Environmental Protection Agency set their limits for drinking water at 4 parts per trillion for two common types — PFOA and PFOS — that are phased out of manufacturing but still are present in the environment.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store